Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Study Protocol

Published on 24 Jul 2024

Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial

in Multiple Sclerosis and Neuroimmunology

Amel Zertal
Kanza Alami Marrouni
Nathalie Arbour
Didier Jutras-Aswad
Marie-Pascale Pomey
Isabelle Rouleau
Alexandre Prat
Catherine Larochelle
Pierre Beaulieu
Laury Chamelian

Frontiers in Neurology

doi 10.3389/fneur.2024.1440678

2,468 views

Study Protocol

Published on 18 Jul 2024

Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study

in Multiple Sclerosis and Neuroimmunology

Giovanna Borriello
Clara Grazia Chisari
Davide Maimone
Massimiliano Mirabella
Damiano Paolicelli
Francesco Assogna
Sandro Caradonna
Francesco Patti

Frontiers in Neurology

doi 10.3389/fneur.2024.1422078

1,949 views

Case Report

Published on 17 Jul 2024

Stiff-person syndrome in association with Hashimoto’s thyroiditis: a case report

in Multiple Sclerosis and Neuroimmunology

Mingzhu Chen
Zhou Hong
Haicun Shi
Chunmei Wen
Yuan Shen

Frontiers in Neurology

doi 10.3389/fneur.2024.1360222

2,117 views

Original Research

Published on 16 Jul 2024

Paramagnetic rim lesions as a biomarker to discriminate between multiple sclerosis and cerebral small vessel disease

in Multiple Sclerosis and Neuroimmunology

Zhibao Zhu
Yuanyuan Zhang
Chun Li
Wenliang Guo
Zhili Chen
Wei Chen
Shaowu Li
Ning Wang
Xiaochun Chen
Ying Fu

Frontiers in Neurology

doi 10.3389/fneur.2024.1429698

1,953 views

Brief Research Report

Published on 08 Jul 2024

Advancing understanding of the role of IL-22 in myelination: insights from the Cuprizone mouse model

in Multiple Sclerosis and Neuroimmunology

Imen Zamali
Ines Elbini
Raja Rekik
Nour-Elhouda Neili
Wafa Ben Hamouda
Ahlem Ben Hmid
Raoudha Doghri
Mélika Ben Ahmed

Frontiers in Neurology

doi 10.3389/fneur.2024.1411143

1,236 views

Original Research

Published on 03 Jul 2024

Usefulness of bioelectrical impedance analysis in multiple sclerosis patients—the interrelationship to the body mass index

in Multiple Sclerosis and Neuroimmunology

Edyta Matusik

Frontiers in Neurology

doi 10.3389/fneur.2024.1409038

938 views

Review

Published on 03 Jul 2024

The complement system in neurodegenerative and inflammatory diseases of the central nervous system

in Multiple Sclerosis and Neuroimmunology

Luciana Negro-Demontel
Adam F. Maleki
Daniel S. Reich
Claudia Kemper

Frontiers in Neurology

doi 10.3389/fneur.2024.1396520

4,665 views
5 citations

Original Research

Published on 27 Jun 2024

Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system

in Multiple Sclerosis and Neuroimmunology

Cristina Scavone
Antonietta Anatriello
Isabella Baccari
Andrea Cantone
Daniele Di Giulio Cesare
Francesca Futura Bernardi
Ornella Moreggia
Valerio Liguori
Vincenzo Andreone
Giorgia Teresa Maniscalco

Frontiers in Neurology

doi 10.3389/fneur.2024.1383910

2,362 views

Original Research

Published on 26 Jun 2024

A comparative study on anti-MOG and anti-AQP4 associated optic neuritis following mild COVID-19: insights from a Chinese single-center experience

in Multiple Sclerosis and Neuroimmunology

Liang Sun
Jiawei Wang
Qinglin Yang
Yanjun Guo

Frontiers in Neurology

doi 10.3389/fneur.2024.1416493

1,300 views

Original Research

Published on 21 Jun 2024

Predictive value of synaptic plasticity for functional decline in patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Carolin Balloff
Lisa Kathleen Janßen
Christian Johannes Hartmann
Sven Günther Meuth
Alfons Schnitzler
Iris-Katharina Penner
Philipp Albrecht

Frontiers in Neurology

doi 10.3389/fneur.2024.1410673

1,296 views

Systematic Review

Published on 18 Jun 2024

Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series

in Multiple Sclerosis and Neuroimmunology

Cristina Scavone
Valerio Liguori
Olusola Jephthah Adungba
Daniele Di Giulio Cesare
Maria Giuseppa Sullo
Vincenzo Andreone
Liberata Sportiello
Giorgia Teresa Maniscalco
Annalisa Capuano

Frontiers in Neurology

doi 10.3389/fneur.2024.1386527

1,854 views

Original Research

Published on 12 Jun 2024

Abnormal brain spontaneous neural activity in neuromyelitis optica spectrum disorder with neuropathic pain

in Multiple Sclerosis and Neuroimmunology

Gendi Wang
Xiang Chen
Xiaoyuan Wang
Yinghui Duan
Hanqing Gao
Xiaopei Ji
Yunfei Zhu
Xuanyi Xiang
Hairong Ma
Yonggang Li

Frontiers in Neurology

doi 10.3389/fneur.2024.1408759

1,261 views

Perspective

Published on 10 Jun 2024

Sex differences in Huntington's disease from a neuroinflammation perspective

in Multiple Sclerosis and Neuroimmunology

Grace Risby-Jones
John D. Lee
Trent M. Woodruff
Jenny N. Fung

Frontiers in Neurology

doi 10.3389/fneur.2024.1384480

3,425 views
2 citations

Original Research

Published on 05 Jun 2024

Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation

in Multiple Sclerosis and Neuroimmunology

Leonardo Marchi
Alice Mariottini
Vittorio Viti
Andrea Bianchi
Chiara Nozzoli
Anna Maria Repice
Riccardo Boncompagni
Andrea Ginestroni
Valentina Damato
Alessandro Barilaro

Frontiers in Neurology

doi 10.3389/fneur.2024.1373385

1,647 views
2 citations

Case Report

Published on 05 Jun 2024

A case report of AQP4-IgG-seropositive refractory neuromyelitis optica spectrum disorder patient with Sjögren’s syndrome and pancytopenia treated with inebilizumab

in Multiple Sclerosis and Neuroimmunology

Shasha Li
Yuting Gao
Yang He
Zhaoxu Zhang

Frontiers in Neurology

doi 10.3389/fneur.2024.1371515

1,656 views

Original Research

Published on 23 May 2024

Effect of methylphenidate on oculomotor function in individuals with multiple sclerosis: a pilot randomized placebo-controlled trial

in Multiple Sclerosis and Neuroimmunology

Timothy J. Rich
Aubree Alexander
Ekaterina Dobryakova
Nancy D. Chiaravalloti
John DeLuca
Silvana L Costa

Frontiers in Neurology

doi 10.3389/fneur.2024.1393877

1,440 views